Capnography is the amount of carbon dioxide, breathed out from a patient. It helps diagnose fundamental circulatory impairment and respiratory illnesses. Capnography facilitates data regarding the production of carbon dioxide, alveolar aeration, permeation and pattern of respiration.
In the last few years, the capnography market has experienced significant development. It is projected to continue in a similar fashion owing to developments in technology. The market is also propelled ahead by growing respiratory and congenital cardiac illnesses.
The alteration of capnography into transportable instruments also escalates the need for the former. North America, Asia Pacific, Europe and rest of the world are the four geographical regions of the worldwide capnography market. The market is leaded by North America.